Concepedia
Statistics
Publications
10
Citations
1.6K
H-Index
Active since
1989
Affiliations
University of Colorado Denver(Current)
University of Colorado Cancer Center
University of Colorado Health
University of Colorado Anschutz Medical Campus
B. Helfrich is an author at University of Colorado Denver specializing in molecular oncology, medicine, and oncology.
Publications per year
1989–2013
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
K E Ware, Trista K. Hinz, Emily K. Kleczko et al. · Oncogenesis · 2013 · 256 citations · Full text
Medicine, Oncology, Pharmacology +17
Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas
Fred R. Hirsch, M. Varella-Garcia, Wilbur A. Franklin et al. · British Journal of Cancer · 2002 · 247 citations · Full text
Medicine, Molecular Biology, Oncology +17
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
Glen J. Weiss, Lynne Bemis, Eri Nakajima et al. · Annals of Oncology · 2008 · 241 citations
The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer
David Raben, B. Helfrich, Daniel C. Chan et al. · Clinical Cancer Research · 2005 · 241 citations
Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
Ariel Soriano, B. Helfrich, Daniel C. Chan et al. · PubMed · 1999 · 192 citations
Medicine, Oncology, Pharmacology +14
1–5 of 10